Watchlist Price Alert

Corcept Therapeutics (CORT)

NASDAQ: CORT · Real-Time Price · USD

71.05

0.15 (0.21%)

At close: Jun 17, 2025, 2:27 PM

Corcept Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	127.67M	135.55M	436.62M	335.81M	476.89M	315.31M	206.76M	104.03M	51.54M
Short-Term Investments	255.67M	232.67M	365.34M	145.92M	364.51M	244.69M	165.13M	57.68M	n/a
Long-Term Investments	219.83M	57.18M	4.95M	112.28M	36.2M	39.35M	n/a	15.28M	n/a
Other Long-Term Assets	10.19M	14.79M	17.17M	14.4M	13.37M	10.54M	7.79M	3.24M	2.86M
Receivables	53.98M	41.12M	31.06M	27.63M	26.2M	19.93M	17.59M	28.2M	9.86M
Inventory	12.41M	7.73M	17.03M	17.95M	21.16M	17.41M	16.24M	8.38M	2.33M
Other Current Assets	10.57M	15.7M	30.42M	1.4M	6.7M	6.04M	7.74M	n/a	n/a
Total Current Assets	471.6M	458.64M	498.71M	381.39M	524.25M	352.65M	240.59M	140.6M	65.69M
Property-Plant & Equipment	8.01M	315K	1.14M	514K	2.51M	3.45M	655K	518K	205K
Goodwill & Intangibles	n/a	n/a	n/a	-112.28M	-36.2M	-39.35M	n/a	-15.8M	n/a
Total Long-Term Assets	368.95M	162.88M	84.72M	42.37M	47.48M	59.66M	71.1M	79.94M	3.06M
Total Assets	840.55M	621.52M	583.43M	423.76M	571.73M	412.31M	311.69M	220.54M	68.75M
Account Payables	15.38M	17.4M	11.98M	6.91M	10.55M	7.54M	8.27M	8.58M	2.29M
Deferred Revenue	n/a	18.47M	11.1M	11.17M	9.41M	n/a	n/a	n/a	10.1M
Short-Term Debt	829K	n/a	1.14M	526K	n/a	n/a	n/a	n/a	14.66M
Other Current Liabilities	124.38M	29M	42.63M	24.28M	202K	20.54M	17.89M	12.42M	n/a
Total Current Liabilities	140.77M	104.5M	81.59M	6.91M	10.55M	41.13M	35.81M	29.57M	27.37M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	20.19M	10.31M	9.1M	409K	398K	386K	239K	n/a	n/a
Total Long-Term Liabilities	20.19M	10.31M	9.1M	41.04M	37.84M	1.9M	239K	n/a	n/a
Total Liabilities	160.96M	114.81M	81.59M	47.95M	48.39M	41.13M	35.81M	29.57M	27.37M
Total Debt	6.94M	151K	1.14M	526K	2.55M	3.46M	n/a	n/a	14.66M
Common Stock	136K	133K	131K	127K	122K	120K	117K	115K	113K
Retained Earnings	543.74M	402.53M	296.39M	194.97M	82.46M	-23.55M	-117.74M	-193.15M	-322.27M
Comprehensive Income	-217K	609K	-869K	-227K	415K	261K	-70K	-75K	-452K
Shareholders Equity	679.59M	506.7M	501.84M	375.81M	523.34M	371.18M	275.88M	190.97M	41.38M
Total Investments	475.5M	289.85M	370.29M	258.19M	400.7M	284.05M	165.13M	72.96M	n/a